[Growth factors in the pathogenesis of malignant diseases].
Rodeck
U
U
Menssen
H D
HD
Herlyn
M
M
D000818:Animals; D046508:Culture Techniques; D004815:Epidermal Growth Factor / Q000502:physiology; D005346:Fibroblast Growth Factors / Q000502:physiology; D006131:Growth Inhibitors / Q000627:therapeutic use; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007335:Insulin-Like Growth Factor II / Q000502:physiology; D009369:Neoplasms / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D009374:Neoplasms, Experimental / Q000628:therapy; D010982:Platelet-Derived Growth Factor / Q000502:physiology
D006131:Growth Inhibitors; D006133:Growth Substances; D010982:Platelet-Derived Growth Factor; D005346:Fibroblast Growth Factors; D004815:Epidermal Growth Factor; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II
Wachstumsfaktoren in der Pathogenese maligner Erkrankungen.